Afya (AFYA)
(Real Time Quote from BATS)
$18.37 USD
+0.64 (3.61%)
Updated Jul 22, 2024 03:00 PM ET
2-Buy of 5 2
A Value A Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AFYA 18.37 +0.64(3.61%)
Will AFYA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AFYA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AFYA
AFYA vs. BFAM: Which Stock Is the Better Value Option?
Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion
AFYA: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Top Small Cap Stocks to Buy Now
Best Growth Stocks to Buy for July 18th
New Strong Buy Stocks for July 18th
Other News for AFYA
AFYA Makes Bullish Cross Above Critical Moving Average
Afya Limited Announces Medical Seats Increase in UNIMA Alagoas
Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz
Afya price target lowered by $2 at Morgan Stanley, here's why
Afya's Results Are Improving And The Market Is Undervaluing It